CMP: $23

Mylan Inc. is a global generic and specialty pharmaceuticals company. The Company operates an active pharmaceutical ingredient manufacturer and runs a specialty business focused on respiratory, allergy, and psychiatric therapies.

Mylan is a $10 Billion market cap company trading at a P/E of little over 18. Revenues have risen from $5.09 Billion to $6.12 Billion in the last 2 years. Profits have risen from $93 Million to $536 Millions in the last 2 years. Profit margins have risen from 2% to well over 8% in the last 2 years. It looks a great buy for long term.